Genasys Inc. — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Genasys reported preliminary Q3 FY2026 revenue of $7.0–7.5 million with gross margins 55–58% and adjusted EBITDA loss of ($3.0)–($3.3) million. Revenue was constrained by supply-chain delays on the CROWS II program (now resolved, expected to ship in Q4) and a deliberate pause on the Puerto Rico Early Warning System project pending customer payments, which have since commenced. Backlog stands at $69 million; management expects Q4 to be the strongest quarter in company history.
Why this rating
Q3 results miss and current loss are modest relative to $66.9M market cap. Sequential execution delays are temporary. $69M backlog (103% of market cap) and management's record-year guidance suggest recovery, but contingent on Puerto Rico payment timing and CROWS execution.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.